CRP and major depressive disorder: A recent meta-analysis estimated the prevalence of low-grade inflammation, defined as the elevation of the acute-phase reactant C-reactive protein (CRP) to >3 mg/L, to be nearly 30% in a sample of patients with MDD [169].